Kessler Elizabeth A, Vora Sheetal S, & Verbsky James W. (2012). Risk of significant cytopenias after treatment with tocilizumab in systemic juvenile arthritis patients with a history of macrophage activation syndrome. BMC.
Chicago Style (17th ed.) CitationKessler Elizabeth A, Vora Sheetal S, and Verbsky James W. Risk of Significant Cytopenias After Treatment with Tocilizumab in Systemic Juvenile Arthritis Patients with a History of Macrophage Activation Syndrome. BMC, 2012.
MLA (9th ed.) CitationKessler Elizabeth A, et al. Risk of Significant Cytopenias After Treatment with Tocilizumab in Systemic Juvenile Arthritis Patients with a History of Macrophage Activation Syndrome. BMC, 2012.
Warning: These citations may not always be 100% accurate.